Jack B. Jewett, President & CEO of the Flinn Foundation, to be honored with the Jon W. McGarity Arizona Bioscience Leader of the Year Award by the Arizona BioIndustry Association.
Category Archives: AZBio News
Riddell and TGen Team Up with Arizona State University’s Football Program to Further Genetic Research into Athlete Concussion Detection and Treatment
2014 Football Season Marks the Second Year of the Research Partnership; Study Using Sun Devils’ Head Impact Data and Genetic Information Could Help Improve Player Protection, Inform New Helmet Designs and Refine Smart Helmet TechnologyContinue reading
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
PHOENIX, AZ–(Aug 25, 2014) – Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pharmaceutical cannabidiol (CBD) for the treatment of glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in humans.Continue reading
Share Your Talents and Help Launch AZ Biotech Companies
Looking for an Opportunity to Create IMPACT? Explore Serving as a TLA Partner with a Purpose.
Ventana Planning New Distribution Center in Marana Arizona
Construction of a 60,000-square-foot logistics and distribution center for Ventana Medical Systems is scheduled to begin by year’s end in Marana.Continue reading
$9 Million Gift to Support the University of Arizona’s Veterinary Medical and Surgical Program
Thanks to a Kemper and Ethel Marley Foundation gift, the UA will be able to launch Arizona’s first public program to train Doctors of Veterinary Medicine.Continue reading
VENTANA System for Primary Diagnosis receives CE mark
New CE mark in the European Union extends application to routine pathology including primary diagnosis with human tissue specimens Continue reading
Are You Ready to Be The BUZZ of BIO?
BIO just announced the Buzz of BIO, recognizing the most innovative companies at annual BIO Investor Forum, an investor conference focused on early and established private companies as well as emerging public companies. This year’s event will take place October 7-8 in San Francisco.
Before the Recess: Washington Update for CSBA
Legislators wrapped up their summer work in July before leaving town for the August recess, but not without some last minute drama over the Highway Trust Fund (HTF) and the border supplemental bill. Ultimately, lawmakers passed a funding extension for the Highway Trust Fund (HTF), staving off a financial crisis. Congress also moved forward on several tax items and continued to hold oversight hearings on the Affordable Care Act (ACA) implementation.Continue reading